GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Cyclically Adjusted Price-to-FCF

Newron Pharmaceuticals SpA (XSWX:NWRN) Cyclically Adjusted Price-to-FCF : (As of Oct. 31, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Newron Pharmaceuticals SpA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Cyclically Adjusted Price-to-FCF Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Newron Pharmaceuticals SpA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF falls into.



Newron Pharmaceuticals SpA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Newron Pharmaceuticals SpA's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Newron Pharmaceuticals SpA's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.536/119.7000*119.7000
=-0.536

Current CPI (Dec23) = 119.7000.

Newron Pharmaceuticals SpA Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.950 99.721 -1.140
201512 -1.021 99.814 -1.224
201612 -1.439 100.300 -1.717
201712 -0.607 101.200 -0.718
201812 -1.011 102.300 -1.183
201912 -1.348 102.800 -1.570
202012 -0.946 102.600 -1.104
202112 -0.669 106.600 -0.751
202212 -0.614 119.000 -0.618
202312 -0.536 119.700 -0.536

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Newron Pharmaceuticals SpA  (XSWX:NWRN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Newron Pharmaceuticals SpA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Dr. Ulrich Köstlin Supervisory Board
Non-exec. Director Luca Benatti Supervisory Board
Patrick Langlois Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines